What are the recommended screening programs for Familial Adenomatous Polyposis (FAP)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Screening Programs for Familial Adenomatous Polyposis (FAP)

For individuals with FAP, screening should begin in early adolescence with flexible sigmoidoscopy every 1-2 years starting at age 10-14 years and continue lifelong in mutation carriers to reduce colorectal cancer morbidity and mortality. 1

Genetic Testing and Initial Screening

  • Genetic counseling and APC mutation analysis should be offered to all patients with suspected FAP, as identifying the causative mutation allows for targeted screening of at-risk family members 1
  • Full germline genetic testing of APC should include DNA sequencing and large rearrangement analysis 1
  • In families where the causative mutation is identified, presymptomatic testing should be offered to first-degree relatives 1
  • When no mutation is identified, all at-risk family members should undergo colorectal screening 1

Colorectal Screening Protocols

For Classical FAP:

  • Flexible sigmoidoscopy or colonoscopy every 1-2 years starting at age 10-11 years and continued lifelong in mutation carriers 1, 2
  • Once adenomas are detected, annual colonoscopy should be performed until colectomy is planned 1
  • Surgery is indicated when there are large numbers of adenomas or adenomas showing high-grade dysplasia 1
  • In at-risk individuals from families without an identified APC mutation, surveillance should be carried out every 2 years until age 40, every 3-5 years between 40-50 years, and may be discontinued at age 50 if no polyposis develops 1

For Attenuated FAP (AFAP):

  • Total colonoscopy (not just sigmoidoscopy) every 2 years starting at age 18-20 years and continued lifelong in mutation carriers 1
  • Once adenomas are detected, annual colonoscopy should be performed 1
  • Some patients with AFAP can be conservatively managed with colonoscopy every 1-2 years and polypectomy 1

Screening for Extracolonic Manifestations

  • Gastroduodenal endoscopy using both front and side-view scopes should be performed when colorectal polyposis is diagnosed or at age 25-30 years, whichever comes first 1, 2
  • Surveillance intervals for upper GI screening are based on the Spigelman stage (severity of duodenal polyposis) 1
  • Annual cervical ultrasonography is recommended for thyroid cancer screening 2
  • Regular physical examination and abdominal CT should be performed for desmoid tumors, especially in patients with a family history of desmoids or after abdominal surgery 2

Post-Surgical Surveillance

  • After colorectal surgery, surveillance of the rectum or pouch should be carried out every 6-12 months if rectal tissue remains 1
  • For patients with ileoanal pouch, surveillance should be performed every 6 months to 5 years depending on polyp burden 1
  • The decision on the type of colorectal surgery (total colectomy with ileorectal anastomosis vs. proctocolectomy with ileal pouch-anal anastomosis) depends on the patient's age, severity of rectal polyposis, desire for children, risk of developing desmoids, and possibly the site of the mutation in the APC gene 1, 2

Special Considerations

  • Patients with mutations between codons 1250 and 1464, especially codon 1309, have a more severe form of FAP and may require more aggressive surveillance 1, 3
  • Patients with mutations within codons 1055 and 1262 may have a higher risk of developing advanced colorectal carcinomas and require special attention 3
  • In approximately 30-40% of FAP cases, there is no family history, suggesting a de novo mutation origin 1
  • Attention must be paid to FAP-related symptoms (increasing bowel frequency, rectal bleeding, mucous discharge) in children at risk, especially those with mutations at codon 1309 who may develop severe polyposis before age 10 1

Implementing these screening protocols has been shown to reduce colorectal cancer incidence and mortality in FAP patients by allowing early detection and intervention before malignant transformation occurs 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Screening and Management of Familial Adenomatous Polyposis (FAP)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Molecular and clinical study of familial adenomatous polyposis for genetic testing and management.

Journal of experimental & clinical cancer research : CR, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.